To further investigate whether TCL6 exerts synergistic cytotoxicity effects with PTX in RCC cells, we modified the expression level of TCL6 and analyzed its impacts on the cell viability and apoptosis of 786-O and Caki-1 cells. The gene discussed is TCL6; the disease is renal cell carcinoma.